A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

NCT01270386 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: apatinib
DRUG: placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]